Talk:Valdecoxib

I, Hitesh Chavda, P.G.student from India want to know the standard curve of valecoxib. Can you give few information about this curve.

Please ask the reference desk. JFW | T@lk 13:18, 5 Apr 2005 (UTC)

nomenclature

Folkes, If I am not mistaken the heterocyclic moiety of Bextra should be an "Isoxazol". Can somebody rectify this? Thanks —Preceding unsigned comment added by Chzapf (talk • contribs)

Corrected. Thank you for noticing. Fvasconcellos 15:21, 8 October 2006 (UTC)

availability

The infobox says it's withdrawn in the US, EU, Canada and parts of Asia - is there anywhere it is still available? Are there any chances of it being reintroduced in the markets it's been withdrawn from?

2009 settlement

Currently the article goes into quite a bit of detail about the legal issues related to off-label promotion. This content is not really about valdecoxib - there were several drugs involved, not just valdecoxib. This section is much more relevant to the pharmaceutical companies involved/ I feel that it could be mentioned here, but not in such detail that it dominates the article text as it does now. It should be trimmed considerably. -- Ed (Edgar181) 14:34, 20 December 2012 (UTC)

I came to this page from a google search precisely because I was interested in reading about the legal issues and the large fine... You can add links in a 'see also' section to the other drugs involved but I think that if you put this information on the main page of the pharma company it will be harder to find, read and reference. This is a very short article and keeping this info here doesn't harm it in any way - in fact it makes it more useful for a general audience. 124.177.161.93 (talk) 04:23, 15 February 2013 (UTC)

A new article should created for this court case because it's about more than one drug. None of the info should be deleted though until the new article is created. It actually needs to be expanded because it's unclear exactly what Pfizer did. Mr G (talk) 03:26, 7 November 2021 (UTC)